CARDIOMYOPATHIES
Clinical trials for CARDIOMYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHIES trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThis study tests the long-term safety and tolerability of acoramidis, an oral medication that stabilizes the transthyretin protein, in people newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition that can lead to heart failure. Participants who complete…
Matched conditions: CARDIOMYOPATHIES
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Zapping heart scars: could one radiation dose replace drugs for dangerous rhythms?
Disease control Not yet recruitingThis study tests a non-invasive radiation treatment called STAR for people with a dangerous fast heart rhythm caused by heart scarring. Instead of using medications or a catheter procedure, a single targeted dose of radiation is delivered to the scarred area. The goal is to see i…
Matched conditions: CARDIOMYOPATHIES
Phase: NA • Sponsor: Southlake Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pacing technique could improve heart function in AF and heart failure patients
Disease control Not yet recruitingThis study compares a newer pacing method called Left Bundle Branch Area Pacing (LBBAP) with the standard coronary sinus pacing for cardiac resynchronization therapy in 44 adults who have both permanent atrial fibrillation and heart failure. The goal is to see if LBBAP better imp…
Matched conditions: CARDIOMYOPATHIES
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Tiny study tracks heart Drug's journey in healthy men
Knowledge-focused Not yet recruitingThis early-stage study will give a small dose of a radioactive-labeled drug called HRS-1893 to 6 healthy men. Researchers will track how the drug is absorbed, broken down, and eliminated through urine and feces. The goal is to understand the drug's path in the body, which is a ke…
Matched conditions: CARDIOMYOPATHIES
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to predict which heart patients will respond to therapy
Knowledge-focused Not yet recruitingThis study will observe 253 adults with heart rhythm problems who are scheduled for procedures like pacemakers or ablation. Researchers will use advanced imaging and AI tools to understand why some patients respond well to treatment while others do not. The goal is to find better…
Matched conditions: CARDIOMYOPATHIES
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New tool aims to protect cancer Survivors' hearts
Knowledge-focused Not yet recruitingThis study tests a computer tool that helps doctors and cancer survivors decide together on the best heart-protective medications and tests. Researchers will enroll 60 cancer survivors at risk for heart problems. The goal is to see if the tool is easy to use and helps people foll…
Matched conditions: CARDIOMYOPATHIES
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC